INS and type 2 diabetes mellitus: In contrast, data from a meta-analysis of 18 short-term controlled feeding trials (209 subjects) indicated that isocaloric fructose replacement by other CHOs resulted in clinically significant improvements in glycemic control, equivalent to a ~0.53% reduction in HbA1c, without significantly affecting insulin in patients with T2DM.